A Cannabis-Based Drug Dramatically Reduced PTSD Nightmares
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. THCMental HealthSleepResearchAnxietyNeurologySafety Why This Matters Clinicians treating PTSD patients now have evidence…
CBD vs. THC: The differences between these marijuana components
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. CBDTHCResearchSafetyDosingHempIndustry Why This Matters Clinicians need to understand the distinct pharmacological…
What Makes a High-Quality Medical Cannabis Clinic?
✦ New CED Clinical Relevance #77 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. SafetyDosingMental HealthPainAnxietyIndustryResearch Why This Matters Clinicians need to understand quality…
Texas THC Ban Remains as Federal Judge Denies Emergency Pause
The Texas THC ban remains in place after a federal judge denied emergency relief. The broader hemp lawsuit and a preliminary-injunction request are still pending. CED explains what changed, what remains uncertain, and why legal availability does not…
Bipartisan Bill Proposes Federal Rules for Hemp THC Drinks
The Beverage Regulatory Parity Act would create federal rules for qualifying hemp THC drinks. The proposal includes a 5-milligram serving cap, age 21 sales, testing, labels, permits, and state authority. It is newly introduced legislation, not current…
Artelo Doses First Patient in Phase 2 Glaucoma Trial
✦ New CED Clinical Relevance #47 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchSafetyNeurologyDosingCBDIndustryAging Why This Matters Clinicians treating glaucoma patients need to monitor…
THC drug eliminated nightmares for over a third of PTSD patients in German trial
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. THCMental HealthSleepResearchAnxietyNeurologySafety Why This Matters Clinicians treating PTSD patients with nightmares…
Artelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologySafetyCBDDosingIndustryPain Why This Matters This Phase 2 trial of ART27.13, a cannabinoid compound,…
Teens Who Started Using Cannabis Showed Slower Growth in Memory and Attention, a …
✦ New CED Clinical Relevance #67 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchNeurologyPediatricsMental HealthSafetyTHCAnxiety Why This Matters Adolescent cannabis use appears to impair…
Study: Cannabinoids Significantly Improve Insomnia Symptoms, Sleep Quality and Sleep Duration
✦ New CED Clinical Relevance #80 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. SleepResearchCBDTHCSafetyDosingMental Health Why This Matters Clinicians managing insomnia patients now have…